Although EoE is immunologically distinct from GERD, PPIs demonstrate efficacy via both acid suppression and anti-inflammatory effects (reducing eotaxin-3 expression) [43,45,46]. The gene discussed is CCL26; the disease is gastroesophageal reflux disease.